Related references
Note: Only part of the references are listed.Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
R. DUCHMANN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
Genetics of inflammatory bowel disease: clues to pathogenesis
Hu Zhang et al.
BRITISH MEDICAL BULLETIN (2008)
Laboratory evaluation of inflammatory bowel disease
Allison Wong et al.
CURRENT OPINION IN PEDIATRICS (2008)
Mouse models of inflammatory bowel disease
Stefan Wirtz et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice
Tatiana Rochat et al.
MICROBIAL CELL FACTORIES (2007)
Blockade of colony stimulating factor-1 (CSF-1) leads to inhibition of DSS-induced colitis
Diane Marshall et al.
INFLAMMATORY BOWEL DISEASES (2007)
Chemically induced mouse models of intestinal inflammation
Stefan Wirtz et al.
NATURE PROTOCOLS (2007)
Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: Toward prenatal prevention of early-onset intestinal diseases
A. L. David et al.
HUMAN GENE THERAPY (2006)
Oral administration of probiotic bacteria (E-coli Nissle, E-coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice
A. Kokesova et al.
FOLIA MICROBIOLOGICA (2006)
Engineered E coli delivers therapeutic genes to the colonic mucosa
I Castagliuolo et al.
GENE THERAPY (2005)
Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
GF Fu et al.
CANCER GENE THERAPY (2005)
A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation
O Erel
CLINICAL BIOCHEMISTRY (2004)
Bacteria-mediated DNA transfer in gene therapy and vaccination
H Loessner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Review article: the aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms
AU Dignass et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Genetically engineered probiotics
L Steidler
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease
H Herfarth et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2003)
IL-10 gene therapy prevents TNBS-induced colitis
J Lindsay et al.
GENE THERAPY (2002)
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
Y Ikeda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Distribution of ethanol-induced protein adducts in vivo:: Relationship to tissue injury
O Niemelä
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Therapy for Crohn disease
WJ Sandborn
CURRENT OPINION IN GASTROENTEROLOGY (2000)
Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
B Egger et al.
DIGESTION (2000)
Share Paper
